Altered L-arginine/nitric oxide synthase/nitric oxide pathway in the vascular adventitia of rats with sepsis

Clinical and Experimental Pharmacology and Physiology

Volumn 33, Issue 12, 2006, Pages 1202-1208

  Jia, Yue Xia ^a,f   Pan, Chun Shui ^a   Yang, Jing Hui ^b   Liu, Xiu Hua ^d   Yuan, Wen Jun ^e   Zhao, Jing ^b   Tang, Chao Shu ^a,c   Qi, Yong Fen ^a,b,c  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d CHINESE PLA GENERAL HOSPITAL   (China)

^e SECOND MILITARY MEDICAL UNIVERSITY   (China)

^f NINGXIA MEDICAL UNIVERSITY   (China)

Author keywords

Cationic amino acid transporter; L arginine; Nitric oxide; Nitric oxide synthase; Sepsis

Indexed keywords

AMINO ACID TRANSPORTER; ARGININE; GLUCOSE; INTERLEUKIN 8; LACTIC ACID; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ABDOMINAL AORTA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL WALL; BRADYCARDIA; CONTROLLED STUDY; GENE EXPRESSION; HEART LEFT VENTRICLE DP-DT; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEMODYNAMICS; HYPOGLYCEMIA; LACTASE DEFICIENCY; MEAN ARTERIAL PRESSURE; NONHUMAN; PROTEIN BLOOD LEVEL; RAT; SEPSIS; THORACIC AORTA; UPREGULATION;

ANIMALS; AORTA, THORACIC; ARGININE; BLOOD PRESSURE; BLOOD VESSELS; CATIONIC AMINO ACID TRANSPORTER 1; CATIONIC AMINO ACID TRANSPORTER 2; CHEMOKINE CCL2; CONNECTIVE TISSUE; HEART RATE; INTERLEUKIN-8; KINETICS; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEPSIS; SHOCK, SEPTIC; UP-REGULATION; VENTRICULAR FUNCTION, LEFT;

EID: 33845533614     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2006.04498.x     Document Type: Article

References (35)

1. Kumar A, Brar R, Wang P et al. Role of nitric oxide and cGMP in human septic serum-induced depression of cardiac myocyte contractility. Am. J. Physiol. 1999; 276: R265-76.
2. Llorens S, Nava E. Cardiovascular diseases and the nitric oxide pathway. Curr. Vasc. Pharmacol. 2003; 1: 335-46.
3. Hallemeesch MM, Janssen BJ, de Jonge WJ, Soeters PB, Lamers WH, Deutz NE. NO production by cNOS and iNOS reflects blood pressure changes in LPS-challenged mice. Am. J. Physiol. Endocrinol. Metab. 2003; 285: E871-5.
4. Denninger JW, Marletta MA. Guanylate cyclase and the NO/cGMP signaling pathway. Biochim. Biophys. Acta 1999; 1411: 334-50.
5. Mullershausen F, Russwurm M, Koesling D, Friebe A. In vivo reconstitution of the negative feedback in nitric oxide/cGMP signaling: Role of phosphodiesterase type 5 phosphorylation. Mol. Biol. Cell. 2004; 15: 4023-30.
6. Dedkova EN, Ji X, Lipsius SL, Blatter LA. Mitochondrial calcium uptake stimulates nitric oxide production in mitochondria of bovine vascular endothelial cells. Am. J. Physiol. Cell Physiol. 2004; 286: C406-15.
7. Feihl F, Waeber B, Liaudet L. Is nitric oxide overproduction the target of choice for the management of septic shock? Pharmacol. Ther. 2001; 91: 179-213.
8. Schott CA, Gray GA, Stoclet JC. Dependence of endotoxin-induced vascular hyporeactivity on extracellular L-arginine. Br. J. Pharmacol. 1993; 108: 38-43.
9. Low BC, Ross IK, Grigor MR. Characterization of system L and system y1 amino acid transport activity in cultured vascular smooth muscle cells. J. Cell. Physiol. 1993; 156: 626-34.
10. Li C, Huang W, Harris MB, Goolsby JM, Venema RC. Interaction of the endothelial nitric oxide synthase with the CAT-1 arginine transporter enhances NO release by a mechanism not involving arginine transport. Biochem. J. 2005; 386: 567-74.
11. Simmons WW, Closs EI, Cunningham JM, Smith TW, Kelly RA. Cytokines and insulin induce cationic amino acid transporter (CAT) expression in cardiac myocytes. Regulation of L-arginine transport and no production by CAT-1, CAT-2A, and CAT-2B. J. Biol. Chem. 1996; 271: 11 694-702.
12. Vekony N, Wolf S, Boissel JP, Gnauert K, Closs EI. Human cationic amino acid transporter hCAT-3 is preferentially expressed in peripheral tissues. Biochemistry 2001; 40: 12 387-94.
13. Hammermann R, Brunn G, Racke K. Analysis of the genomic organization of the human cationic amino acid transporters CAT-1, CAT-2 and CAT-4. Amino Acids 2001; 21: 211-19.
14. Miljkovic D, Trajkovic V. Inducible nitric oxide synthase activation by interleukin-17. Cytokine Growth Factor Rev. 2004; 15: 21-32.
15. Kleschyov AL, Muller B, Keravis T, Stoeckel ME, Stoclet JC. Adventitia-derived nitric oxide in rat aortas exposed to endotoxin: Cell origin and functional consequences. Am. J. Physiol. Heart Circ. Physiol. 2000; 279: H2743-51.
16. Muller B, Kleschyov AL, Gyorgy K, Stoclet JC. Inducible NO synthase activity in blood vessels and heart: New insight into cell origin and consequences. Physiol. Res. 2000; 49: 19-26.
17. Wichterman KA, Baue AE, Chaudry IH. Sepsis and septic shock: A review of laboratoary models and a proposal. J. Surg. Res. 1980; 29: 189-201.
18. Tang CS, Liu MS. Initial externalization followed by internalization of β-adrenergic receptors in rat heart during sepsis. Am. J. Physiol. 1996; 270: R254-63.
19. +)-ATPase in rat heart during different phases of sepsis. Circ. Shock 1993; 41: 19-25.
20. Battle T, Arnal JF, Challan M, Michel JB. Selective isolation of rat aortic wall layers and their cell types in culture: Application to converting enzyme activity measurement. Tissue Cell 1994; 26: 943-55.
21. Stathopulos PB, Lu X, Shen J et al. Increased L-arginine uptake and inducible nitric oxide synthase activity in aortas of rats with heart failure. Am. J. Physisol. Heart Circ. Physiol. 2001; 280: H859-67.
22. Li S, Huang FL, Feng Q, Liu J, Fan SX, McKenna TM. Overexpression of protein kinase C enhances lilpopolysaccharide-induced nitric oxide formation in vascular smooth muscle cells. J. Cell Physiol. 1998; 176: 402-11.
23. Bradford MM. A rapid and sensitive method for as the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976; 72: 248-54.
24. Zeng XK, Guan YF, Remick DG, Wang X. Signal pathways underlying homocysteine-induced production of MCP-1 and IL-8 in cultured human whole blood. Acta Pharmacol. Sin. 2005; 26: 85-91.
25. Qi YF, Bu DF, Niu da D et al. Effects of different peptide fragments derived from proadrenomedullin on gene expression of adrenomedullin gene. Peptides 2002; 23: 1141-7.
26. Feihl F, Waeber B, Liaudet L. Is nitric oxide overproduction the target of choice for the management of septic shock? Pharmacol. Ther. 2001; 91: 179-213.
27. Kang MK, Jhee EC, Koo BS et al. Induction of nitric oxide synthase expression by Vibrio vulnificus cytolysin. Biochem. Biophys. Res. Commun. 2002; 290: 1090-5.
28. Lirk P, Hoffmann G, Rieder J. Inducible nitric oxide synthase: Time for reappraisal. Curr. Drug Targets Inflamm. Allergy 2002; 1: 89-108.
29. Closs EI, Mann GE. Membrane transport of L-arginine and cationic amino acid transport. In: Ignarro L, Orlando FL (eds). Nitric Oxide: Principles of Biology. Academic Press, San Diego. 2001; 225-41.
30. Kone BC, Kuncewicz T, Zhang W, Yu ZY. Protein interactions with nitric oxide synthases: Controlling the right time, the right place, and the right amount of nitric oxide. Am. J. Physiol. Renal Physiol. 2003; 285: F178-90.
31. Nathan, C, Xie QW. Nitric oxide synthases: Roles, tolls, and controls. Cell 1994; 78: 915-18.
32. Kakoki M, Kim HS, Arendshorst WJ, Mattson DL. L-Arginine uptake affects nitric oxide production and blood flow in the renal medulla. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004; 287: R1478-85.
33. Harbrecht BG, Perpetua M, Fulmer M, Zhang B. Glucagon regulates hepatic inducible nitric oxide synthesis in vivo. Shock 2004; 22: 157-62.
34. Visigalli R, Bussolati O, Sala R et al. The stimulation of arginine transport by TNFalpha in human endothelial cells depends on NF-kappaB activation. Biochim. Biophys. Acta 2004; 1664: 45-52.
35. Hattori Y, Kasai K, Gross SS. Cationic amino acid transporter gene expression in cultured vascular smooth muscle cells and in rats. Am. J. Physiol. 1999; 276: H2020-8.